[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Non Narcotic Analgesics Market Report 2017

December 2017 | 96 pages | ID: U15D2A7EB58EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Non Narcotic Analgesics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Non Narcotic Analgesics in these regions, from 2012 to 2022 (forecast).
United States Non Narcotic Analgesics market competition by top manufacturers/players, with Non Narcotic Analgesics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Sanofi S.A.
  • Novartis AG
  • GlaxoSmithKline PLC
  • Pfizer
  • Reckitt Benckiser
  • Endo Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Non Steroid Antiinflammatory Drug
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Medical Center
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Non Narcotic Analgesics Market Report 2017

1 NON NARCOTIC ANALGESICS OVERVIEW

1.1 Product Overview and Scope of Non Narcotic Analgesics
1.2 Classification of Non Narcotic Analgesics by Product Category
  1.2.1 United States Non Narcotic Analgesics Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Non Narcotic Analgesics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Non Steroid Antiinflammatory Drug
  1.2.4 Others
1.3 United States Non Narcotic Analgesics Market by Application/End Users
  1.3.1 United States Non Narcotic Analgesics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Medical Center
  1.3.4 Others
1.4 United States Non Narcotic Analgesics Market by Region
  1.4.1 United States Non Narcotic Analgesics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Non Narcotic Analgesics Status and Prospect (2012-2022)
  1.4.3 Southwest Non Narcotic Analgesics Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Non Narcotic Analgesics Status and Prospect (2012-2022)
  1.4.5 New England Non Narcotic Analgesics Status and Prospect (2012-2022)
  1.4.6 The South Non Narcotic Analgesics Status and Prospect (2012-2022)
  1.4.7 The Midwest Non Narcotic Analgesics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Non Narcotic Analgesics (2012-2022)
  1.5.1 United States Non Narcotic Analgesics Sales and Growth Rate (2012-2022)
  1.5.2 United States Non Narcotic Analgesics Revenue and Growth Rate (2012-2022)

2 UNITED STATES NON NARCOTIC ANALGESICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Non Narcotic Analgesics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Non Narcotic Analgesics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Non Narcotic Analgesics Average Price by Players/Suppliers (2012-2017)
2.4 United States Non Narcotic Analgesics Market Competitive Situation and Trends
  2.4.1 United States Non Narcotic Analgesics Market Concentration Rate
  2.4.2 United States Non Narcotic Analgesics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Non Narcotic Analgesics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NON NARCOTIC ANALGESICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Non Narcotic Analgesics Sales and Market Share by Region (2012-2017)
3.2 United States Non Narcotic Analgesics Revenue and Market Share by Region (2012-2017)
3.3 United States Non Narcotic Analgesics Price by Region (2012-2017)

4 UNITED STATES NON NARCOTIC ANALGESICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Non Narcotic Analgesics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Non Narcotic Analgesics Revenue and Market Share by Type (2012-2017)
4.3 United States Non Narcotic Analgesics Price by Type (2012-2017)
4.4 United States Non Narcotic Analgesics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES NON NARCOTIC ANALGESICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Non Narcotic Analgesics Sales and Market Share by Application (2012-2017)
5.2 United States Non Narcotic Analgesics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES NON NARCOTIC ANALGESICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi S.A.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Non Narcotic Analgesics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi S.A. Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis AG
  6.2.2 Non Narcotic Analgesics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis AG Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline PLC
  6.3.2 Non Narcotic Analgesics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GlaxoSmithKline PLC Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Non Narcotic Analgesics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Reckitt Benckiser
  6.5.2 Non Narcotic Analgesics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Reckitt Benckiser Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Endo Pharmaceuticals
  6.6.2 Non Narcotic Analgesics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Endo Pharmaceuticals Non Narcotic Analgesics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 NON NARCOTIC ANALGESICS MANUFACTURING COST ANALYSIS

7.1 Non Narcotic Analgesics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Non Narcotic Analgesics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Non Narcotic Analgesics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Non Narcotic Analgesics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NON NARCOTIC ANALGESICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Non Narcotic Analgesics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Non Narcotic Analgesics Sales Volume Forecast by Type (2017-2022)
11.3 United States Non Narcotic Analgesics Sales Volume Forecast by Application (2017-2022)
11.4 United States Non Narcotic Analgesics Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Non Narcotic Analgesics
Figure United States Non Narcotic Analgesics Market Size (K Pcs) by Type (2012-2022)
Figure United States Non Narcotic Analgesics Sales Volume Market Share by Type (Product Category) in 2016
Figure Non Steroid Antiinflammatory Drug Product Picture
Figure Others Product Picture
Figure United States Non Narcotic Analgesics Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Non Narcotic Analgesics by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Non Narcotic Analgesics Market Size (Million USD) by Region (2012-2022)
Figure The West Non Narcotic Analgesics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Non Narcotic Analgesics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Non Narcotic Analgesics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Non Narcotic Analgesics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Non Narcotic Analgesics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Non Narcotic Analgesics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Non Narcotic Analgesics Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Non Narcotic Analgesics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Non Narcotic Analgesics Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Non Narcotic Analgesics Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Non Narcotic Analgesics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Non Narcotic Analgesics Sales Share by Players/Suppliers
Figure 2017 United States Non Narcotic Analgesics Sales Share by Players/Suppliers
Figure United States Non Narcotic Analgesics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Non Narcotic Analgesics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Non Narcotic Analgesics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Non Narcotic Analgesics Revenue Share by Players/Suppliers
Figure 2017 United States Non Narcotic Analgesics Revenue Share by Players/Suppliers
Table United States Market Non Narcotic Analgesics Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Non Narcotic Analgesics Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Non Narcotic Analgesics Market Share of Top 3 Players/Suppliers
Figure United States Non Narcotic Analgesics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Non Narcotic Analgesics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Non Narcotic Analgesics Product Category
Table United States Non Narcotic Analgesics Sales (K Pcs) by Region (2012-2017)
Table United States Non Narcotic Analgesics Sales Share by Region (2012-2017)
Figure United States Non Narcotic Analgesics Sales Share by Region (2012-2017)
Figure United States Non Narcotic Analgesics Sales Market Share by Region in 2016
Table United States Non Narcotic Analgesics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Non Narcotic Analgesics Revenue Share by Region (2012-2017)
Figure United States Non Narcotic Analgesics Revenue Market Share by Region (2012-2017)
Figure United States Non Narcotic Analgesics Revenue Market Share by Region in 2016
Table United States Non Narcotic Analgesics Price (USD/Pcs) by Region (2012-2017)
Table United States Non Narcotic Analgesics Sales (K Pcs) by Type (2012-2017)
Table United States Non Narcotic Analgesics Sales Share by Type (2012-2017)
Figure United States Non Narcotic Analgesics Sales Share by Type (2012-2017)
Figure United States Non Narcotic Analgesics Sales Market Share by Type in 2016
Table United States Non Narcotic Analgesics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Non Narcotic Analgesics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Non Narcotic Analgesics by Type (2012-2017)
Figure Revenue Market Share of Non Narcotic Analgesics by Type in 2016
Table United States Non Narcotic Analgesics Price (USD/Pcs) by Types (2012-2017)
Figure United States Non Narcotic Analgesics Sales Growth Rate by Type (2012-2017)
Table United States Non Narcotic Analgesics Sales (K Pcs) by Application (2012-2017)
Table United States Non Narcotic Analgesics Sales Market Share by Application (2012-2017)
Figure United States Non Narcotic Analgesics Sales Market Share by Application (2012-2017)
Figure United States Non Narcotic Analgesics Sales Market Share by Application in 2016
Table United States Non Narcotic Analgesics Sales Growth Rate by Application (2012-2017)
Figure United States Non Narcotic Analgesics Sales Growth Rate by Application (2012-2017)
Table Sanofi S.A. Basic Information List
Table Sanofi S.A. Non Narcotic Analgesics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi S.A. Non Narcotic Analgesics Sales Growth Rate (2012-2017)
Figure Sanofi S.A. Non Narcotic Analgesics Sales Market Share in United States (2012-2017)
Figure Sanofi S.A. Non Narcotic Analgesics Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Non Narcotic Analgesics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Non Narcotic Analgesics Sales Growth Rate (2012-2017)
Figure Novartis AG Non Narcotic Analgesics Sales Market Share in United States (2012-2017)
Figure Novartis AG Non Narcotic Analgesics Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline PLC Basic Information List
Table GlaxoSmithKline PLC Non Narcotic Analgesics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline PLC Non Narcotic Analgesics Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline PLC Non Narcotic Analgesics Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline PLC Non Narcotic Analgesics Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Non Narcotic Analgesics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Non Narcotic Analgesics Sales Growth Rate (2012-2017)
Figure Pfizer Non Narcotic Analgesics Sales Market Share in United States (2012-2017)
Figure Pfizer Non Narcotic Analgesics Revenue Market Share in United States (2012-2017)
Table Reckitt Benckiser Basic Information List
Table Reckitt Benckiser Non Narcotic Analgesics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Reckitt Benckiser Non Narcotic Analgesics Sales Growth Rate (2012-2017)
Figure Reckitt Benckiser Non Narcotic Analgesics Sales Market Share in United States (2012-2017)
Figure Reckitt Benckiser Non Narcotic Analgesics Revenue Market Share in United States (2012-2017)
Table Endo Pharmaceuticals Basic Information List
Table Endo Pharmaceuticals Non Narcotic Analgesics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Endo Pharmaceuticals Non Narcotic Analgesics Sales Growth Rate (2012-2017)
Figure Endo Pharmaceuticals Non Narcotic Analgesics Sales Market Share in United States (2012-2017)
Figure Endo Pharmaceuticals Non Narcotic Analgesics Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non Narcotic Analgesics
Figure Manufacturing Process Analysis of Non Narcotic Analgesics
Figure Non Narcotic Analgesics Industrial Chain Analysis
Table Raw Materials Sources of Non Narcotic Analgesics Major Players/Suppliers in 2016
Table Major Buyers of Non Narcotic Analgesics
Table Distributors/Traders List
Figure United States Non Narcotic Analgesics Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Non Narcotic Analgesics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Non Narcotic Analgesics Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Non Narcotic Analgesics Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Non Narcotic Analgesics Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Non Narcotic Analgesics Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Non Narcotic Analgesics Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Non Narcotic Analgesics Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Non Narcotic Analgesics Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Non Narcotic Analgesics Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Non Narcotic Analgesics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Non Narcotic Analgesics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Non Narcotic Analgesics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications